CIP
ATRC icon

Champlain Investment Partners’s AtriCure ATRC Stock Holding History

Champlain Investment Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3M Sell
938,567
-32,544
-3% -$916K 0.67% 66
2026
Q1 		$27.7M Sell
971,111
-202,494
-17% -$6.91M 0.35% 96
2025
Q4 		$46.4M Sell
1,173,605
-804,608
-41% -$29.5M 0.47% 85
2025
Q3 		$69.7M Sell
1,978,213
-38,541
-2% -$1.33M 0.53% 81
2025
Q2 		$66.1M Sell
2,016,754
-121,209
-6% -$3.94M 0.46% 93
2025
Q1 		$69M Sell
2,137,963
-390,651
-15% -$14.5M 0.5% 85
2024
Q4 		$77.3M Sell
2,528,614
-262,144
-9% -$8.43M 0.49% 88
2024
Q3 		$78.3M Buy
2,790,758
+115,813
+4% +$2.85M 0.47% 86
2024
Q2 		$60.9M Sell
2,674,945
-6,055
-0.2% -$140K 0.37% 98
2024
Q1 		$81.6M Buy
2,681,000
+575,605
+27% +$19.3M 0.47% 87
2023
Q4 		$75.1M Buy
2,105,395
+253,855
+14% +$9.44M 0.45% 89
2023
Q3 		$81.1M Buy
1,851,540
+41,155
+2% +$2.01M 0.53% 82
2023
Q2 		$89.4M Sell
1,810,385
-81,710
-4% -$3.77M 0.55% 78
2023
Q1 		$78.4M Sell
1,892,095
-47,645
-2% -$1.98M 0.49% 86
2022
Q4 		$86.1M Sell
1,939,740
-71,000
-4% -$2.97M 0.55% 80
2022
Q3 		$78.6M Buy
2,010,740
+391,760
+24% +$17.9M 0.54% 82
2022
Q2 		$66.2M Buy
1,618,980
+343,160
+27% +$16.3M 0.43% 95
2022
Q1 		$83.8M Buy
1,275,820
+57,270
+5% +$3.71M 0.43% 91
2021
Q4 		$84.7M Sell
1,218,550
-1,970
-0.2% -$143K 0.38% 103
2021
Q3 		$84.9M Sell
1,220,520
-340,715
-22% -$26.2M 0.41% 99
2021
Q2 		$124M Sell
1,561,235
-613,905
-28% -$44.6M 0.59% 76
2021
Q1 		$143M Buy
2,175,140
+39,560
+2% +$2.44M 0.74% 59
2020
Q4 		$119M Buy
2,135,580
+66,160
+3% +$2.86M 0.68% 64
2020
Q3 		$82.6M Buy
2,069,420
+410,185
+25% +$17.4M 0.56% 69
2020
Q2 		$74.6M Sell
1,659,235
-33,990
-2% -$1.48M 0.54% 74
2020
Q1 		$56.9M Buy
1,693,225
+443,585
+35% +$15.9M 0.51% 77
2019
Q4 		$40.6M Buy
1,249,640
+574,205
+85% +$16.3M 0.3% 104
2019
Q3 		$16.8M Buy
+675,435
New +$19.3M 0.14% 112

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Champlain Investment Partners's ATRC Position: Q2 2026 in Review

Champlain Investment Partners reduced its AtriCure (ATRC) stake by 3.4% in Q2 2026, selling an estimated $916K and leaving 938,567 shares worth $26.3M. The position accounts for 0.67% of the portfolio, ranked #66.

Champlain Investment Partners first reported a position in ATRC in Q3 2019 and has held it in 28 quarters since. The position peaked at $143M in Q1 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Champlain Investment Partners held 938,567 shares of AtriCure worth $26.3M as of Q2 2026.
  • Champlain Investment Partners sold 32,544 AtriCure shares in Q2 2026, an estimated $916K.
  • AtriCure made up 0.67% of Champlain Investment Partners's portfolio in Q2 2026, its #66 holding.
  • Champlain Investment Partners first reported a position in AtriCure in Q3 2019 and has held it in 28 quarters since.
  • Champlain Investment Partners's AtriCure position peaked at $143M in Q1 2021.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.